Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-012591

Senior Vice President and CFO sold 3,250 shares at $9.20 ($29,900)

  • Senior Vice President and CFO acquired 3,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-20 Exercise or conversion : show line 1 in the form +3,250 $3.78 $12,285 144,710 D
2017-03-20 Sale : show line 2 in the form −3,250 $9.20 $29,900 141,460 D
Open-market sales · 3,250 sh · avg $9.20 · $29,900

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-20 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −3,250 $3.78 2021-07-01 3,250 55,805 D
Loading xslF345X03/form4.xml…